메뉴 건너뛰기




Volumn 32, Issue 9, 2017, Pages 1448-1453

Fibroblast growth factor 23 actions in inflammation: A key factor in CKD outcomes

Author keywords

CKD; FGF23; Inflammation; Neutrophils

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR;

EID: 85029810791     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw331     Document Type: Article
Times cited : (27)

References (89)
  • 1
    • 84855854046 scopus 로고    scopus 로고
    • Chronic kidney disease
    • Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379: 165-180
    • (2012) Lancet , vol.379 , pp. 165-180
    • Levey, A.S.1    Coresh, J.2
  • 2
    • 84959894121 scopus 로고    scopus 로고
    • FGF23 signaling impairs neutrophil recruitment and host defense during CKD
    • Rossaint J, Oehmichen J, Van Aken H et al. FGF23 signaling impairs neutrophil recruitment and host defense during CKD. J Clin Invest 2016; 126: 962-974
    • (2016) J Clin Invest , vol.126 , pp. 962-974
    • Rossaint, J.1    Oehmichen, J.2    Van Aken, H.3
  • 3
    • 80555148939 scopus 로고    scopus 로고
    • FGF23 induces left ventricular hypertrophy
    • Faul C, Amaral AP, Oskouei B et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 4393-4408
    • (2011) J Clin Invest , vol.121 , pp. 4393-4408
    • Faul, C.1    Amaral, A.P.2    Oskouei, B.3
  • 4
    • 79957870135 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
    • Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79: 1370-1378
    • (2011) Kidney Int , vol.79 , pp. 1370-1378
    • Isakova, T.1    Wahl, P.2    Vargas, G.S.3
  • 5
    • 76149101238 scopus 로고    scopus 로고
    • Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active
    • Shimada T, Urakawa I, Isakova T et al. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin EndocrinolMetabol 2010; 95: 578-585
    • (2010) J Clin EndocrinolMetabol , vol.95 , pp. 578-585
    • Shimada, T.1    Urakawa, I.2    Isakova, T.3
  • 6
    • 84884522131 scopus 로고    scopus 로고
    • Fibroblast growth factor-23: What we know, what we don't know, and what we need to know
    • Kovesdy CP, Quarles LD. Fibroblast growth factor-23: what we know, what we don't know, and what we need to know. Nephrol Dial Transplant 2013; 28: 2228-2236
    • (2013) Nephrol Dial Transplant , vol.28 , pp. 2228-2236
    • Kovesdy, C.P.1    Quarles, L.D.2
  • 7
    • 84969988387 scopus 로고    scopus 로고
    • The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy
    • Grabner A, Faul C. The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy. Curr Opin Nephrol Hypertens 2016; 25: 314-324
    • (2016) Curr Opin Nephrol Hypertens , vol.25 , pp. 314-324
    • Grabner, A.1    Faul, C.2
  • 9
    • 0141844575 scopus 로고    scopus 로고
    • Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
    • Liu S, Guo R, Simpson LG et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003; 278: 37419-37426
    • (2003) J Biol Chem , vol.278 , pp. 37419-37426
    • Liu, S.1    Guo, R.2    Simpson, L.G.3
  • 11
    • 34547267177 scopus 로고    scopus 로고
    • Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease
    • Stubbs J, Liu S, Quarles LD. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial 2007; 20: 302-308
    • (2007) Semin Dial , vol.20 , pp. 302-308
    • Stubbs, J.1    Liu, S.2    Quarles, L.D.3
  • 12
    • 0034703619 scopus 로고    scopus 로고
    • Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain
    • Yamashita T, YoshiokaM, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 2000; 277: 494-498
    • (2000) Biochem Biophys Res Commun , vol.277 , pp. 494-498
    • Yamashita, T.1    Yoshioka, M.2    Itoh, N.3
  • 13
    • 33745828096 scopus 로고    scopus 로고
    • Polypeptide galnac-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation
    • Kato K, Jeanneau C, TarpMA et al. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J BiolChem2006; 281: 18370-18377
    • (2006) J BiolChem , vol.281 , pp. 18370-18377
    • Kato, K.1    Jeanneau, C.2    Tarp, M.A.3
  • 14
    • 18444375871 scopus 로고    scopus 로고
    • Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo
    • Shimada T, Muto T, Urakawa I et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 2002; 143: 3179-3182
    • (2002) Endocrinology , vol.143 , pp. 3179-3182
    • Shimada, T.1    Muto, T.2    Urakawa, I.3
  • 15
    • 84856720641 scopus 로고    scopus 로고
    • Regulation and function of the FGF23/klotho endocrine pathways
    • Martin A, David V, Quarles LD. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 2012; 92: 131-155
    • (2012) Physiol Rev , vol.92 , pp. 131-155
    • Martin, A.1    David, V.2    Quarles, L.D.3
  • 16
    • 1642416884 scopus 로고    scopus 로고
    • Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and Vitamin D metabolism
    • Shimada T, Kakitani M, Yamazaki Y et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004; 113: 561-568
    • (2004) J Clin Invest , vol.113 , pp. 561-568
    • Shimada, T.1    Kakitani, M.2    Yamazaki, Y.3
  • 17
    • 13544270218 scopus 로고    scopus 로고
    • An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
    • Benet-Pages A, Orlik P, Strom TM et al. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. HumMol Genet 2005; 14: 385-390
    • (2005) HumMol Genet , vol.14 , pp. 385-390
    • Benet-Pages, A.1    Orlik, P.2    Strom, T.M.3
  • 18
    • 34250667000 scopus 로고    scopus 로고
    • Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice
    • Stubbs JR, Liu S, Tang W et al. Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 2007; 18: 2116-2124
    • (2007) J Am Soc Nephrol , vol.18 , pp. 2116-2124
    • Stubbs, J.R.1    Liu, S.2    Tang, W.3
  • 19
    • 84888219981 scopus 로고    scopus 로고
    • Calcium regulates FGF-23 expression in bone
    • David V, Dai B, Martin A et al. Calcium regulates FGF-23 expression in bone. Endocrinology 2013; 154: 4469-4482
    • (2013) Endocrinology , vol.154 , pp. 4469-4482
    • David, V.1    Dai, B.2    Martin, A.3
  • 20
    • 33646367420 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 is a counterregulatory phosphaturic hormone for Vitamin D
    • Liu S, Tang W, Zhou J et al. Fibroblast growth factor 23 is a counterregulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 2006; 17: 1305-1315
    • (2006) J Am Soc Nephrol , vol.17 , pp. 1305-1315
    • Liu, S.1    Tang, W.2    Zhou, J.3
  • 21
    • 84857067427 scopus 로고    scopus 로고
    • Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo
    • Lopez I, Rodriguez-Ortiz ME, Almaden Y et al. Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo. Kidney Int 2011; 80: 475-482
    • (2011) Kidney Int , vol.80 , pp. 475-482
    • Lopez, I.1    Rodriguez-Ortiz, M.E.2    Almaden, Y.3
  • 22
    • 84866366740 scopus 로고    scopus 로고
    • Update on fibroblast growth factor 23 in chronic kidney disease
    • Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 2012; 82: 737-747
    • (2012) Kidney Int , vol.82 , pp. 737-747
    • Wolf, M.1
  • 23
    • 32444451549 scopus 로고    scopus 로고
    • Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
    • Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006; 116: 288-296
    • (2006) J Clin Invest , vol.116 , pp. 288-296
    • Remuzzi, G.1    Benigni, A.2    Remuzzi, A.3
  • 24
    • 84555187565 scopus 로고    scopus 로고
    • Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease
    • Stubbs JR, He N, Idiculla A et al. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease. J BoneMiner Res 2012; 27: 38-46
    • (2012) J BoneMiner Res , vol.27 , pp. 38-46
    • Stubbs, J.R.1    He, N.2    Idiculla, A.3
  • 25
    • 34548230927 scopus 로고    scopus 로고
    • Getting to the site of inflammation: The leukocyte adhesion cascade updated
    • Ley K, Laudanna C, Cybulsky MI et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7: 678-689
    • (2007) Nat Rev Immunol , vol.7 , pp. 678-689
    • Ley, K.1    Laudanna, C.2    Cybulsky, M.I.3
  • 26
    • 81255188938 scopus 로고    scopus 로고
    • The neutrophil in vascular inflammation
    • Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med 2011; 17: 1381-1390
    • (2011) Nat Med , vol.17 , pp. 1381-1390
    • Phillipson, M.1    Kubes, P.2
  • 27
    • 0242368135 scopus 로고    scopus 로고
    • Arrest chemokines
    • Ley K. Arrest chemokines.Microcirculation 2003; 10: 289-295
    • (2003) Microcirculation , vol.10 , pp. 289-295
    • Ley, K.1
  • 28
    • 79957984039 scopus 로고    scopus 로고
    • Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease a crosssectional study of predialysis, dialysis and kidney-transplantation patients
    • Recio-Mayoral A, Banerjee D, Streather C et al. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease-A crosssectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 2011; 216: 446-451
    • (2011) Atherosclerosis , vol.216 , pp. 446-451
    • Recio-Mayoral, A.1    Banerjee, D.2    Streather, C.3
  • 29
    • 84923104493 scopus 로고    scopus 로고
    • Update on inflammation in chronic kidney disease
    • Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif 2015; 39: 84-92
    • (2015) Blood Purif , vol.39 , pp. 84-92
    • Akchurin, O.M.1    Kaskel, F.2
  • 30
    • 5444257487 scopus 로고    scopus 로고
    • Oxidative stress in uremia: Nature, mechanisms, and potential consequences
    • Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469-473
    • (2004) Semin Nephrol , vol.24 , pp. 469-473
    • Vaziri, N.D.1
  • 31
    • 84871731386 scopus 로고    scopus 로고
    • Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC
    • Gupta J, Mitra N, Kanetsky PA et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 2012; 7: 1938-1946
    • (2012) Clin J Am Soc Nephrol , vol.7 , pp. 1938-1946
    • Gupta, J.1    Mitra, N.2    Kanetsky, P.A.3
  • 33
    • 77950277183 scopus 로고    scopus 로고
    • Cytokine patterns and survival in haemodialysis patients
    • Cohen SD, Phillips TM, Khetpal P et al. Cytokine patterns and survival in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 1239-1243
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 1239-1243
    • Cohen, S.D.1    Phillips, T.M.2    Khetpal, P.3
  • 34
    • 84872893571 scopus 로고    scopus 로고
    • Preventing and treating inflammation: Role of dialysis access management
    • Nassar GM. Preventing and treating inflammation: role of dialysis access management. Semin Dial 2013; 26: 28-30
    • (2013) Semin Dial , vol.26 , pp. 28-30
    • Nassar, G.M.1
  • 35
    • 84896725954 scopus 로고    scopus 로고
    • Prevalence and severity of oral disease in adults with chronic kidney disease: A systematic review of observational studies
    • Ruospo M, Palmer SC, Craig JC et al. Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrol Dial Transplant 2014; 29: 364-375
    • (2014) Nephrol Dial Transplant , vol.29 , pp. 364-375
    • Ruospo, M.1    Palmer, S.C.2    Craig, J.C.3
  • 36
    • 84935142799 scopus 로고    scopus 로고
    • Platelets in leucocyte recruitment and function
    • Rossaint J, Zarbock A. Platelets in leucocyte recruitment and function. Cardiovasc Res 2015; 107: 386-395
    • (2015) Cardiovasc Res , vol.107 , pp. 386-395
    • Rossaint, J.1    Zarbock, A.2
  • 37
    • 49249104701 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
    • Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
    • (2008) N Engl J Med , vol.359 , pp. 584-592
    • Gutierrez, O.M.1    Mannstadt, M.2    Isakova, T.3
  • 38
    • 79958724181 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease
    • Isakova T, Xie H, Yang W et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011; 305: 2432-2439
    • (2011) JAMA , vol.305 , pp. 2432-2439
    • Isakova, T.1    Xie, H.2    Yang, W.3
  • 39
    • 84954426824 scopus 로고    scopus 로고
    • Low Vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study
    • Chonchol M, Greene T, Zhang Y et al. Low vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study. J Am SocNephrol 2016; 27: 227-237
    • (2016) J Am SocNephrol , vol.27 , pp. 227-237
    • Chonchol, M.1    Greene, T.2    Zhang, Y.3
  • 40
    • 84942884771 scopus 로고    scopus 로고
    • Cause of death in patients with reduced kidney function
    • Thompson S, James M, Wiebe N et al. Cause of death in patients with reduced kidney function. J AmSoc Nephrol 2015; 26: 2504-2511
    • (2015) J AmSoc Nephrol , vol.26 , pp. 2504-2511
    • Thompson, S.1    James, M.2    Wiebe, N.3
  • 41
    • 84863550146 scopus 로고    scopus 로고
    • FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
    • Shalhoub V, Shatzen EM, Ward SC et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest 2012; 122: 2543-2553
    • (2012) J Clin Invest , vol.122 , pp. 2543-2553
    • Shalhoub, V.1    Shatzen, E.M.2    Ward, S.C.3
  • 42
    • 30944441131 scopus 로고    scopus 로고
    • Progression of kidney disease: Blocking leukocyte recruitment with chemokine receptor CCR1 antagonists
    • Anders HJ, Ninichuk V, Schlondorff D. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int 2006; 69: 29-32
    • (2006) Kidney Int , vol.69 , pp. 29-32
    • Anders, H.J.1    Ninichuk, V.2    Schlondorff, D.3
  • 43
    • 0141618429 scopus 로고    scopus 로고
    • The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing
    • Anding K, Gross P, Rost JMet al. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant 2003; 18: 2067-2073
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 2067-2073
    • Anding, K.1    Gross, P.2    Rost, J.M.3
  • 44
    • 84857083564 scopus 로고    scopus 로고
    • Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling
    • Rossaint J, Spelten O, Kassens N et al. Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling. Kidney Int 2011; 80: 493-503
    • (2011) Kidney Int , vol.80 , pp. 493-503
    • Rossaint, J.1    Spelten, O.2    Kassens, N.3
  • 45
    • 84872841888 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes
    • Bacchetta J, Sea JL, Chun RF et al. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 2013; 28: 46-55
    • (2013) J Bone Miner Res , vol.28 , pp. 46-55
    • Bacchetta, J.1    Sea, J.L.2    Chun, R.F.3
  • 46
    • 84869233330 scopus 로고    scopus 로고
    • Uremia suppresses immune signalinduced CYP27B1 expression in human monocytes
    • Viaene L, Evenepoel P, Meijers B et al. Uremia suppresses immune signalinduced CYP27B1 expression in human monocytes. Am J Nephrol 2012; 36: 497-508
    • (2012) Am J Nephrol , vol.36 , pp. 497-508
    • Viaene, L.1    Evenepoel, P.2    Meijers, B.3
  • 47
    • 0038375031 scopus 로고    scopus 로고
    • Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease
    • Stenvinkel P. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease. J RenNutr 2003; 13: 144-148 | |
    • (2003) J RenNutr , vol.13 , pp. 144-148
    • Stenvinkel, P.1
  • 48
    • 81255188938 scopus 로고    scopus 로고
    • The neutrophil in vascular inflammation
    • Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med 2011; 17: 1381-1390
    • (2011) Nat Med , vol.17 , pp. 1381-1390
    • Phillipson, M.1    Kubes, P.2
  • 49
    • 0242368135 scopus 로고    scopus 로고
    • Arrest chemokines
    • Ley K. Arrest chemokines.Microcirculation 2003; 10: 289-295
    • (2003) Microcirculation , vol.10 , pp. 289-295
    • Ley, K.1
  • 50
    • 79957984039 scopus 로고    scopus 로고
    • Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease-a crosssectional study of predialysis, dialysis and kidney-transplantation patients
    • Recio-Mayoral A, Banerjee D, Streather C et al. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease-a crosssectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 2011; 216: 446-451
    • (2011) Atherosclerosis , vol.216 , pp. 446-451
    • Recio-Mayoral, A.1    Banerjee, D.2    Streather, C.3
  • 51
    • 84923104493 scopus 로고    scopus 로고
    • Update on inflammation in chronic kidney disease
    • Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif 2015; 39: 84-92
    • (2015) Blood Purif , vol.39 , pp. 84-92
    • Akchurin, O.M.1    Kaskel, F.2
  • 52
    • 5444257487 scopus 로고    scopus 로고
    • Oxidative stress in uremia: Nature, mechanisms, and potential consequences
    • Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469-473
    • (2004) Semin Nephrol , vol.24 , pp. 469-473
    • Vaziri, N.D.1
  • 53
    • 84871731386 scopus 로고    scopus 로고
    • Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC
    • Gupta J, Mitra N, Kanetsky PA et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 2012; 7: 1938-1946
    • (2012) Clin J Am Soc Nephrol , vol.7 , pp. 1938-1946
    • Gupta, J.1    Mitra, N.2    Kanetsky, P.A.3
  • 55
    • 77950277183 scopus 로고    scopus 로고
    • Cytokine patterns and survival in haemodialysis patients
    • Cohen SD, Phillips TM, Khetpal P et al. Cytokine patterns and survival in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 1239-1243
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 1239-1243
    • Cohen, S.D.1    Phillips, T.M.2    Khetpal, P.3
  • 56
    • 84872893571 scopus 로고    scopus 로고
    • Preventing and treating inflammation: Role of dialysis access management
    • Nassar GM. Preventing and treating inflammation: role of dialysis access management. Semin Dial 2013; 26: 28-30
    • (2013) Semin Dial , vol.26 , pp. 28-30
    • Nassar, G.M.1
  • 57
    • 84896725954 scopus 로고    scopus 로고
    • Prevalence and severity of oral disease in adults with chronic kidney disease: A systematic review of observational studies
    • Ruospo M, Palmer SC, Craig JC et al. Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrol Dial Transplant 2014; 29: 364-375
    • (2014) Nephrol Dial Transplant , vol.29 , pp. 364-375
    • Ruospo, M.1    Palmer, S.C.2    Craig, J.C.3
  • 58
    • 84935142799 scopus 로고    scopus 로고
    • Platelets in leucocyte recruitment and function
    • Rossaint J, Zarbock A. Platelets in leucocyte recruitment and function. Cardiovasc Res 2015; 107: 386-395
    • (2015) Cardiovasc Res , vol.107 , pp. 386-395
    • Rossaint, J.1    Zarbock, A.2
  • 59
    • 49249104701 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
    • Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
    • (2008) N Engl J Med , vol.359 , pp. 584-592
    • Gutierrez, O.M.1    Mannstadt, M.2    Isakova, T.3
  • 60
    • 79958724181 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease
    • Isakova T, Xie H, Yang W et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011; 305: 2432-2439
    • (2011) JAMA , vol.305 , pp. 2432-2439
    • Isakova, T.1    Xie, H.2    Yang, W.3
  • 61
    • 84954426824 scopus 로고    scopus 로고
    • Low Vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study
    • Chonchol M, Greene T, Zhang Y et al. Low vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study. J Am SocNephrol 2016; 27: 227-237
    • (2016) J Am SocNephrol , vol.27 , pp. 227-237
    • Chonchol, M.1    Greene, T.2    Zhang, Y.3
  • 62
    • 84942884771 scopus 로고    scopus 로고
    • Cause of death in patients with reduced kidney function
    • Thompson S, James M, Wiebe N et al. Cause of death in patients with reduced kidney function. J AmSoc Nephrol 2015; 26: 2504-2511
    • (2015) J AmSoc Nephrol , vol.26 , pp. 2504-2511
    • Thompson, S.1    James, M.2    Wiebe, N.3
  • 63
    • 84863550146 scopus 로고    scopus 로고
    • FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
    • Shalhoub V, Shatzen EM, Ward SC et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest 2012; 122: 2543-2553
    • (2012) J Clin Invest , vol.122 , pp. 2543-2553
    • Shalhoub, V.1    Shatzen, E.M.2    Ward, S.C.3
  • 64
    • 30944441131 scopus 로고    scopus 로고
    • Progression of kidney disease: Blocking leukocyte recruitment with chemokine receptor CCR1 antagonists
    • Anders HJ, Ninichuk V, Schlondorff D. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int 2006; 69: 29-32
    • (2006) Kidney Int , vol.69 , pp. 29-32
    • Anders, H.J.1    Ninichuk, V.2    Schlondorff, D.3
  • 65
    • 0141618429 scopus 로고    scopus 로고
    • The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing
    • Anding K, Gross P, Rost JMet al. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant 2003; 18: 2067-2073
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 2067-2073
    • Anding, K.1    Gross, P.2    Rost, J.M.3
  • 66
    • 84857083564 scopus 로고    scopus 로고
    • Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling
    • Rossaint J, Spelten O, Kassens N et al. Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling. Kidney Int 2011; 80: 493-503
    • (2011) Kidney Int , vol.80 , pp. 493-503
    • Rossaint, J.1    Spelten, O.2    Kassens, N.3
  • 67
    • 84872841888 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes
    • Bacchetta J, Sea JL, Chun RF et al. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 2013; 28: 46-55
    • (2013) J Bone Miner Res , vol.28 , pp. 46-55
    • Bacchetta, J.1    Sea, J.L.2    Chun, R.F.3
  • 68
    • 84869233330 scopus 로고    scopus 로고
    • Uremia suppresses immune signalinduced CYP27B1 expression in human monocytes
    • Viaene L, Evenepoel P, Meijers B et al. Uremia suppresses immune signalinduced CYP27B1 expression in human monocytes. Am J Nephrol 2012; 36: 497-508
    • (2012) Am J Nephrol , vol.36 , pp. 497-508
    • Viaene, L.1    Evenepoel, P.2    Meijers, B.3
  • 69
    • 0038375031 scopus 로고    scopus 로고
    • Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease
    • Stenvinkel P. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease. J RenNutr 2003; 13: 144-148
    • (2003) J RenNutr , vol.13 , pp. 144-148
    • Stenvinkel, P.1
  • 70
    • 81155152411 scopus 로고    scopus 로고
    • Markers of inflammation predict the longterm risk of developing chronic kidney disease: A population-based cohort study
    • Shankar A, Sun L, Klein BE et al.Markers of inflammation predict the longterm risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 2011; 80: 1231-1238
    • (2011) Kidney Int , vol.80 , pp. 1231-1238
    • Shankar, A.1    Sun, L.2    Klein, B.E.3
  • 71
    • 84866127175 scopus 로고    scopus 로고
    • A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model
    • Dai B, David V, Martin A et al. A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. PLoS One 2012; 7: e44161
    • (2012) PLoS One , vol.7 , pp. e44161
    • Dai, B.1    David, V.2    Martin, A.3
  • 72
    • 84957953317 scopus 로고    scopus 로고
    • Intact FGF23 and alpha-Klotho during acute inflammation/sepsis in CKD patients
    • Dounousi E, Torino C, Pizzini P et al. Intact FGF23 and alpha-Klotho during acute inflammation/sepsis in CKD patients. Eur J Clin Invest 2016; 46: 234-241
    • (2016) Eur J Clin Invest , vol.46 , pp. 234-241
    • Dounousi, E.1    Torino, C.2    Pizzini, P.3
  • 73
    • 84929707931 scopus 로고    scopus 로고
    • Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly
    • Holecki M, Chudek J, Owczarek A et al. Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly. Clin Endocrinol (Oxf) 2015; 82: 900-909
    • (2015) Clin Endocrinol (Oxf) , vol.82 , pp. 900-909
    • Holecki, M.1    Chudek, J.2    Owczarek, A.3
  • 74
    • 84945942478 scopus 로고    scopus 로고
    • Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy
    • Grabner A, Amaral AP, Schramm K et al. Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab 2015; 22: 1020-1032
    • (2015) Cell Metab , vol.22 , pp. 1020-1032
    • Grabner, A.1    Amaral, A.P.2    Schramm, K.3
  • 75
    • 84908565099 scopus 로고    scopus 로고
    • Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli
    • Ito N,Wijenayaka AR, PrideauxM et al. Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli. Mol Cell Endocrinol 2015; 399: 208-218
    • (2015) Mol Cell Endocrinol , vol.399 , pp. 208-218
    • Ito, N.1    Wijenayaka, A.R.2    Prideaux, M.3
  • 76
    • 84969268627 scopus 로고    scopus 로고
    • Inflammation regulates fibroblast growth factor 23 production
    • Francis C, David V. Inflammation regulates fibroblast growth factor 23 production. Curr Opin Nephrol Hypertens 2016; 25: 325-332
    • (2016) Curr Opin Nephrol Hypertens , vol.25 , pp. 325-332
    • Francis, C.1    David, V.2
  • 77
    • 84946130633 scopus 로고    scopus 로고
    • Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
    • David V, Martin A, Isakova T et al. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 2016; 89: 135-146
    • (2016) Kidney Int , vol.89 , pp. 135-146
    • David, V.1    Martin, A.2    Isakova, T.3
  • 78
    • 84896733066 scopus 로고    scopus 로고
    • The iron cycle in chronic kidney disease (CKD): From genetics and experimental models to CKD patients
    • Zumbrennen-Bullough K, Babitt JL. The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients. Nephrol Dial Transplant 2014; 29: 263-273
    • (2014) Nephrol Dial Transplant , vol.29 , pp. 263-273
    • Zumbrennen-Bullough, K.1    Babitt, J.L.2
  • 79
    • 84881241741 scopus 로고    scopus 로고
    • Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
    • Wolf M, Koch TA, Bregman DB. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J BoneMiner Res 2013; 28: 1793-1803
    • (2013) J BoneMiner Res , vol.28 , pp. 1793-1803
    • Wolf, M.1    Koch, T.A.2    Bregman, D.B.3
  • 80
    • 84942848861 scopus 로고    scopus 로고
    • HIF hydroxylase pathways in cardiovascular physiology and medicine
    • Bishop T, Ratcliffe PJ. HIF hydroxylase pathways in cardiovascular physiology and medicine. Circ Res 2015; 117: 65-79
    • (2015) Circ Res , vol.117 , pp. 65-79
    • Bishop, T.1    Ratcliffe, P.J.2
  • 81
    • 84892698159 scopus 로고    scopus 로고
    • Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHRmice
    • Clinkenbeard EL, Farrow EG, Summers LJ et al. Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHRmice. J BoneMiner Res 2014; 29: 361-369
    • (2014) J BoneMiner Res , vol.29 , pp. 361-369
    • Clinkenbeard, E.L.1    Farrow, E.G.2    Summers, L.J.3
  • 82
    • 84857076647 scopus 로고    scopus 로고
    • Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery
    • Colgan SP, Eltzschig HK. Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol 2012; 74: 153-175
    • (2012) Annu Rev Physiol , vol.74 , pp. 153-175
    • Colgan, S.P.1    Eltzschig, H.K.2
  • 83
    • 1642581653 scopus 로고    scopus 로고
    • Hypoxic gene activation by lipopolysaccharide in macrophages: Implication of hypoxia-inducible factor 1alpha
    • Blouin CC, Page EL, Soucy GM et al. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 2004; 103: 1124-1130
    • (2004) Blood , vol.103 , pp. 1124-1130
    • Blouin, C.C.1    Page, E.L.2    Soucy, G.M.3
  • 84
    • 44849100198 scopus 로고    scopus 로고
    • NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha
    • Rius J, Guma M, Schachtrup C et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008; 453: 807-811
    • (2008) Nature , vol.453 , pp. 807-811
    • Rius, J.1    Guma, M.2    Schachtrup, C.3
  • 85
    • 44449174536 scopus 로고    scopus 로고
    • Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia
    • Kuhlicke J, Frick JS, Morote-Garcia JC et al. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One 2007; 2: e1364
    • (2007) PLoS One , vol.2 , pp. e1364
    • Kuhlicke, J.1    Frick, J.S.2    Morote-Garcia, J.C.3
  • 86
    • 14844299760 scopus 로고    scopus 로고
    • Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: Impact on the bioactivation of proproteins
    • McMahon S, Grondin F, McDonald PP et al. Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins. J Biol Chem2005; 280: 6561-6569
    • (2005) J Biol Chem , vol.280 , pp. 6561-6569
    • McMahon, S.1    Grondin, F.2    McDonald, P.P.3
  • 89
    • 77949837759 scopus 로고    scopus 로고
    • Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis
    • 1394e1-2
    • Thurston RD, Larmonier CB, Majewski PM et al. Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis. Gastroenterology 2010; 138: 1384-1394, 1394.e1-2
    • (2010) Gastroenterology , vol.138 , pp. 1384-1394
    • Thurston, R.D.1    Larmonier, C.B.2    Majewski, P.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.